Outlook Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $46k | 43k | 1.06 |
| 2025-03-31 | $126k | 104k | 1.22 |
| 2024-12-31 | $112k | 60k | 1.89 |
| 2024-09-30 | $190k | 36k | 5.34 |